These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9466488)
1. Advances from genetic clues in pancreatic cancer. Kern SE Curr Opin Oncol; 1998 Jan; 10(1):74-80. PubMed ID: 9466488 [TBL] [Abstract][Full Text] [Related]
2. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517 [TBL] [Abstract][Full Text] [Related]
3. [Ductal epithelial lesions and pancreatic adenocarcinoma]. Bentjerodt R; Smok G Rev Med Chil; 1990 Oct; 118(10):1099-104. PubMed ID: 2152626 [TBL] [Abstract][Full Text] [Related]
5. Adenocarcinoma of the minor duodenal papilla and its precursor lesions: a clinical and pathologic study. Shia J; Agaram NP; Olgac S; Cobanov B; Adsay V; Klimstra DS Am J Surg Pathol; 2014 Apr; 38(4):526-33. PubMed ID: 24625417 [TBL] [Abstract][Full Text] [Related]
6. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy. Clarke AR; Cummings MC; Harrison DJ Oncogene; 1995 Nov; 11(9):1913-20. PubMed ID: 7478622 [TBL] [Abstract][Full Text] [Related]
7. Genetic progression in the pancreatic ducts. Hruban RH; Wilentz RE; Kern SE Am J Pathol; 2000 Jun; 156(6):1821-5. PubMed ID: 10854204 [No Abstract] [Full Text] [Related]
8. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma. Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074 [TBL] [Abstract][Full Text] [Related]
9. [Precursors to pancreatic cancer]. Søreide K; Immervoll H; Molven A Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881 [TBL] [Abstract][Full Text] [Related]
10. Molecular pathology of early pancreatic cancer. Remmers N; Bailey JM; Mohr AM; Hollingsworth MA Cancer Biomark; 2010; 9(1-6):421-40. PubMed ID: 22112488 [TBL] [Abstract][Full Text] [Related]
11. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191 [TBL] [Abstract][Full Text] [Related]
12. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination. Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524 [TBL] [Abstract][Full Text] [Related]
13. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium. Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563 [TBL] [Abstract][Full Text] [Related]
14. Premalignant conditions of the pancreas. Hall Pde L; Wilentz RE; de Klerk W; Bornman PP Pathology; 2002 Dec; 34(6):504-17. PubMed ID: 12555988 [TBL] [Abstract][Full Text] [Related]
15. [Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma]. Ott C; Heinmöller E; Gaumann A; Schölmerich J; Klebl F Med Klin (Munich); 2007 Feb; 102(2):127-35. PubMed ID: 17323019 [TBL] [Abstract][Full Text] [Related]
16. Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia. Ozaki N; Ohmuraya M; Ida S; Hashimoto D; Ikuta Y; Chikamoto A; Hirota M; Baba H J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):620-7. PubMed ID: 23475261 [TBL] [Abstract][Full Text] [Related]
17. Recent discoveries in cancer genetics of exocrine pancreatic neoplasia. Hahn SA; Schmiegel WH Digestion; 1998 Aug; 59(5):493-501. PubMed ID: 9705534 [TBL] [Abstract][Full Text] [Related]
18. Serrated polyps and colorectal cancer: new pathway to malignancy. Noffsinger AE Annu Rev Pathol; 2009; 4():343-64. PubMed ID: 19400693 [TBL] [Abstract][Full Text] [Related]
19. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983 [TBL] [Abstract][Full Text] [Related]
20. Argyrophilic nucleolar organizer regions may help the differential diagnostic distinction between chronic pancreatitis and pancreatic ductal adenocarcinoma. Mäkinen K; Eskelinen M; Lipponen P; Pasanen P; Nuutinen P; Alhava E Scand J Gastroenterol; 1994 Nov; 29(11):1029-33. PubMed ID: 7871369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]